Top in GI: Smoking and CRC risk, adrenomedullin and ulcerative colitis

A recent study showed that cigarette smoking was associated with an increased risk for colorectal cancer. It was the top story in gastroenterology last week.

Another top story was about the efficacy of high-dose adrenomedullin in patients with steroid-resistant ulcerative colitis.

Read these and more top stories in gastroenterology below:

Cigarette smoking increases risk for CRC

The risk for colorectal cancer increased with cigarette smoking, according to a study published in the American Journal of Gastroenterology. Read more.

Complete remission at 8 weeks with high-dose adrenomedullin in UC

Complete remission at 8 weeks was observed in patients with steroid-resistant ulcerative colitis who received a high dose of adrenomedullin, according to study published in The Journal of Gastroenterology. Read more.

COVID and IBD: Practical Considerations for IBD Management, Telehealth, and COVID Vaccination

Gil Y. Melmed, MD, MS, discusses evidence on the risk for COVID-19 among patients with inflammatory bowel disease, the pandemic’s effect on elective procedures, the future of telehealth for gastroenterologists and the importance of vaccination in these patients. Read more.

Electroacupuncture shows promise in severe chronic constipation

Electroacupuncture was noninferior to Motegrity (prucalopride, Takeda) for the treatment of patients with severe chronic constipation, according to study results. Read more.

Sustained reduction in pruritus seen with MRX in children with Alagille syndrome

Children with Alagille syndrome who received 48 weeks of Maralixibat (Mirum Pharmaceuticals) had clinically meaningful reduction in pruritus and improvements in quality of life, according to a presentation at The Liver Meeting Digital Experience. Read more.